Ulrich J. Sachs

Giessen, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 135 publications

Diagnosing Immune Thrombocytopenia: An Update.

Diagnosing Immune Thrombocytopenia: An Update.

Journal: Hamostaseologie

Published: August 27, 2026

Paediatric outcomes after maternal nipocalimab for haemolytic disease of the fetus and newborn: an open-label, single-arm study.

Paediatric outcomes after maternal nipocalimab for haemolytic disease of the fetus and newborn: an open-label, single-arm study.

Journal: Archives of disease in childhood. Fetal and neonatal edition

Published: June 04, 2026

In-vitro diagnostics of adult immune thrombocytopenia - status quo and new developments.

In-vitro diagnostics of adult immune thrombocytopenia - status quo and new developments.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: May 06, 2026

Noninvasive Fetal HPA Genotyping for FNAIT: Diagnostic Accuracy and Technical Performance of Molecular Methods.

Noninvasive Fetal HPA Genotyping for FNAIT: Diagnostic Accuracy and Technical Performance of Molecular Methods.

Journal: Transfusion medicine reviews

Published: April 22, 2026

Effects of extended storage of blood samples on the results of platelet function testing: an in vitro stability study.

Effects of extended storage of blood samples on the results of platelet function testing: an in vitro stability study.

Journal: Scandinavian journal of clinical and laboratory investigation

Published: February 14, 2026

Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn.

Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn.

Journal: NEJM evidence

Published: January 27, 2026

Management of Breakthrough Bleeding During Emicizumab Prophylaxis in Acquired Haemophilia A: Data From the GTH-AHA-EMI Study.

Management of Breakthrough Bleeding During Emicizumab Prophylaxis in Acquired Haemophilia A: Data From the GTH-AHA-EMI Study.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: January 20, 2026

Anti-αvβ3 antibodies in FNAIT are associated with disturbed angiogenesis and intracranial hemorrhage in men and mice.

Anti-αvβ3 antibodies in FNAIT are associated with disturbed angiogenesis and intracranial hemorrhage in men and mice.

Journal: Blood

Published: January 02, 2026

Inhibition of human FcγRIII prevents platelet destruction in a dual-humanized murine model of FNAIT.

Inhibition of human FcγRIII prevents platelet destruction in a dual-humanized murine model of FNAIT.

Journal: Blood advances

Published: December 22, 2025

Inhibition of human FcγRIII prevents platelet destruction in a dual-humanized murine model of FNAIT.

Inhibition of human FcγRIII prevents platelet destruction in a dual-humanized murine model of FNAIT.

Journal: Blood advances

Published: December 22, 2025

FcγRIII blockade prevents anti-HLA-mediated platelet clearance in a humanized murine model of platelet transfusion refractoriness.

FcγRIII blockade prevents anti-HLA-mediated platelet clearance in a humanized murine model of platelet transfusion refractoriness.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: November 12, 2025

Persistent ANCA Positivity in Granulicatella adiacens-associated Endocarditis: Diagnostic Implications of Methodological Variability.

Persistent ANCA Positivity in Granulicatella adiacens-associated Endocarditis: Diagnostic Implications of Methodological Variability.

Journal: Kidney international reports

Published: November 05, 2025

Showing 1-12 of 135

Last Updated: 09/26/2026